Williams Hematology Hemostasis and Thrombosis
Table of Contents
Chapter 1. Megakaryopoiesis and Thrombosis
Chapter 2. Platelet Morphology, Biochemistry, and Function
Chapter 3. Molecular Biology and Biochemistry of the Coagulation Factors and Pathways of Hemostasis
Chapter 4. Control of Coagulation Reactions
Chapter 5. Vascular Function in Hemostasis
Chapter 6. Classification, Clinical Manifestations and Evaluation of Disorders of Hemostasis
Chapter 7. Thrombocytopenia
Chapter 8. Heparin-Induced Thrombocytopenia
Chapter 9. Reactive Thrombocytosis
Chapter 10. Hereditary Qualitative Platelet Disorders
Chapter 11. Acquired Qualitative Platelet Disorders
Chapter 12. The Vascular Purpuras
Chapter 13. Hemophilia A and Hemophilia B
Chapter 14. Inherited Deficiencies of Coagulation Factors II, V, V+VIII, VII, X, XI, and XIII
Chapter 15. Hereditary Fibrinogen Abnormalities
Chapter 16. von Willebrand Disease
Chapter 17. Antibody-Mediated Coagulation Factor Deficiencies
Chapter 18. Hemostatic Alterations in Liver Disease and Liver Transplantation
Chapter 19. Disseminated Intravascular Coagulation
Chapter 20. Hereditary Thrombophilia
Chapter 21. The Antiphospholipid Syndrome
Chapter 22. Thrombotic Microangiopathies
Chapter 23. Venous Thrombosis
Chapter 24. Atherothrombosis: Disease Initiation, Progression, and Treatment
Chapter 25. Fibrinolysis and Thrombolysis
Hemostasis and Thrombosis as only Williams can cover it
IN FULL COLOR!
A Doody’s Core Title for 2019!
Featuring twenty-five clinically relevant chapters originally appearing in Williams Hematology, Ninth Edition – many carefully updated by the original authors to reflect the latest developments -- this concise, full-color resource delivers comprehensive and up-to-date coverage of hemostasis and thrombosis.
The result of this unique compilation is a focused, timely resource that will be of particular value to advanced medical students who seeks a more detailed review of hematology than generally presented in second year medical school, medicine and pediatric residents, and hematology/oncology fellows faced with patients with bleeding and clotting disorders on a myriad of medications, and physicians of all levels of life-long learning who wish to remain current with anticoagulant and anti-platelet therapies.